Literature DB >> 27352422

Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression.

O D Konsta1, A Charras, C Le Dantec, E Kapsogeorgeou, A Bordron, W H Brooks, A G Tzioufas, J O Pers, Y Renaudineau.   

Abstract

Sjögren's syndrome (SS) is a chronic autoimmune epithelitis, and several lines of experiments indicate that multifactorial factors contribute to salivary gland epithelial cells (SGEC) dysfunctions including a combination of environmental factors, lymphocytic infiltrations, genetic predispositions as well as epigenetic defects. Such statement is reinforced by the observation that global DNA methylation (5MeCyt) is altered in minor salivary glands from pSS patients and that such defect is associated cytokeratin 19 (KRT19) overexpression. An epigenetic deregulation of the KRT19 gene was further tested by treating the human salivary gland (HSG) cell line with the DNA demethylating agent 5-azacytidin, and with the histone acetylase inhibitor trichostatin A. Blocking DNA methylation, but not histone acetylation, with 5-azacytidin was associated with KRT19 overexpression at both transcriptional and protein level. Next, analysis of the CpG genome-wide methylome array in the KTR19 locus from long term cultured SGEC obtained from 8 pSS patients revealed a more reduced DNA methylation level in those patients with defective global DNA methylation. Altogether, our data, therefore, suggest that alteration of DNA methylation in SGEC may contribute to pSS pathophysiology in part by controlling the expression of KRT19.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27352422

Source DB:  PubMed          Journal:  Bull Group Int Rech Sci Stomatol Odontol        ISSN: 0250-4693


  7 in total

Review 1.  JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's Syndrome.

Authors:  Amandine Charras; Pinelopi Arvaniti; Christelle Le Dantec; Marina I Arleevskaya; Kaliopi Zachou; George N Dalekos; Anne Bordon; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

2.  Epigenetics: DNA methylation signatures in Sjögren syndrome.

Authors:  Yves Renaudineau; Esteban Ballestar
Journal:  Nat Rev Rheumatol       Date:  2016-09-09       Impact factor: 20.543

3.  Abnormal Histones Acetylation in Patients with Primary Sjögren's Syndrome.

Authors:  Xiuying Lv; Mi Zhou; Qi Zhang; Yan He; Ying Wang; Jingxiu Xuan; Guixiu Shi; Yan Li
Journal:  Clin Rheumatol       Date:  2022-01-29       Impact factor: 2.980

Review 4.  The emerging role of epigenetics in human autoimmune disorders.

Authors:  Roberta Mazzone; Clemens Zwergel; Marco Artico; Samanta Taurone; Massimo Ralli; Antonio Greco; Antonello Mai
Journal:  Clin Epigenetics       Date:  2019-02-26       Impact factor: 6.551

Review 5.  Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; Aggeliki Lyberopoulou; Nikolaos K Gatselis; Wesley H Brooks; George N Dalekos; Yves Renaudineau
Journal:  Epigenomes       Date:  2019-08-08

Review 6.  Epigenetic Regulation in the Pathogenesis of Sjögren Syndrome and Rheumatoid Arthritis.

Authors:  José Santiago Ibáñez-Cabellos; Marta Seco-Cervera; Rebeca Osca-Verdegal; Federico V Pallardó; José Luis García-Giménez
Journal:  Front Genet       Date:  2019-11-13       Impact factor: 4.599

7.  JAK Inhibitors and Oxidative Stress Control.

Authors:  Amandine Charras; Pinelopi Arvaniti; Christelle Le Dantec; George N Dalekos; Kaliopi Zachou; Anne Bordron; Yves Renaudineau
Journal:  Front Immunol       Date:  2019-12-06       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.